全文获取类型
收费全文 | 1618篇 |
免费 | 139篇 |
国内免费 | 1篇 |
专业分类
耳鼻咽喉 | 15篇 |
儿科学 | 70篇 |
妇产科学 | 23篇 |
基础医学 | 255篇 |
口腔科学 | 6篇 |
临床医学 | 264篇 |
内科学 | 196篇 |
皮肤病学 | 1篇 |
神经病学 | 191篇 |
特种医学 | 71篇 |
外科学 | 203篇 |
综合类 | 30篇 |
预防医学 | 233篇 |
眼科学 | 25篇 |
药学 | 78篇 |
中国医学 | 1篇 |
肿瘤学 | 96篇 |
出版年
2023年 | 12篇 |
2022年 | 12篇 |
2021年 | 23篇 |
2020年 | 14篇 |
2019年 | 30篇 |
2018年 | 33篇 |
2017年 | 24篇 |
2016年 | 39篇 |
2015年 | 28篇 |
2014年 | 42篇 |
2013年 | 67篇 |
2012年 | 93篇 |
2011年 | 86篇 |
2010年 | 49篇 |
2009年 | 68篇 |
2008年 | 81篇 |
2007年 | 102篇 |
2006年 | 94篇 |
2005年 | 75篇 |
2004年 | 69篇 |
2003年 | 85篇 |
2002年 | 69篇 |
2001年 | 38篇 |
2000年 | 48篇 |
1999年 | 42篇 |
1998年 | 17篇 |
1997年 | 21篇 |
1996年 | 16篇 |
1995年 | 14篇 |
1994年 | 11篇 |
1993年 | 20篇 |
1992年 | 24篇 |
1991年 | 41篇 |
1990年 | 38篇 |
1989年 | 28篇 |
1988年 | 31篇 |
1987年 | 28篇 |
1986年 | 22篇 |
1985年 | 16篇 |
1984年 | 10篇 |
1983年 | 8篇 |
1982年 | 7篇 |
1981年 | 7篇 |
1979年 | 15篇 |
1978年 | 7篇 |
1977年 | 6篇 |
1975年 | 7篇 |
1974年 | 6篇 |
1971年 | 5篇 |
1930年 | 5篇 |
排序方式: 共有1758条查询结果,搜索用时 15 毫秒
1.
2.
3.
4.
5.
6.
7.
T S Rao J A Cler R P Compton M R Emmett S Mick E T Sun S Iyengar P L Wood 《Neuropharmacology》1990,29(3):305-309
Following intravenous administration, 1-aminocyclobutane-1-carboxylate (ACBC, 100 mg/kg), a N-methyl-D-aspartate (NMDA)-associated glycine receptor antagonist, was eliminated with a T1/2 of 5 min in mouse brain and 4 min in rat cerebrospinal fluid (CSF). 1-Aminocyclopropane-1-carboxylate (ACC), a NMDA-associated glycine receptor agonist, was found to have a T1/2 of less than 5 min in mouse brain. ACC and ACBC did not alter basal cerebellar cGMP. Glycine and D-serine increased cGMP, and 1-hydroxy-3-aminopyrrolidone-2 (HA-966), a glycine antagonist, reversed the D-serine-induced increases in cGMP. In contrast, ACBC did not reverse the D-serine-induced increases in cGMP. These data suggest that despite their brain bioavailability and marked potency at the glycine receptor in vitro, ACC and ACBC are rapidly inactivated and thus have limited in vivo utility. 相似文献
8.
A method for evaluating systems of epidemiological surveillance 总被引:3,自引:0,他引:3
S B Thacker R G Parrish F L Trowbridge 《Rapport trimestriel de statistiques sanitaires mondiales》1988,41(1):11-18
Epidemiological surveillance is the systematic collection, analysis and dissemination of health data for the planning, implementation and evaluation of public health programmes. Established surveillance systems should be regularly reviewed on the basis of explicit criteria of usefulness, cost and quality; systems should be modified as a result of such review. Attributes of quality include: (i) sensitivity, (ii) specificity, (iii) representativeness, (iv) timeliness, (v) simplicity, (vi) flexibility and (vii) acceptability. To date, evaluation of surveillance systems has been limited in scope and content. The evaluation method proposed in this article offers an organized approach to the evaluation of epidemiological surveillance systems. The usefulness of a surveillance system is measured by whether it leads to prevention or control or a better understanding of adverse health events. The measure can be qualitative, in terms of the subjective views of those using the system, or quantitative in terms of the impact of surveillance data on policies, interventions or the occurrence of a health event. The cost of a system includes indirect as well as direct costs, and should be measured in relation to the benefits obtained, such as reduction of medical-care expenses and of time lost from work. All elements of the system should be included in the cost: data collection, analysis and dissemination. The sensitivity of a surveillance system is its ability to detect health events (completeness of reporting). Its specificity is inversely proportional to the number of false positives it reports. Reports of a disease that do not meet the case definition are false positives, and may result in resources being wasted in investigating them.(ABSTRACT TRUNCATED AT 250 WORDS) 相似文献
9.
The ideal suture for use within the urinary tract should maintain its tensile strength until wound repair is satisfactory and then it should undergo rapid total absorption without promoting stone formation. The bladder has a great potential for repair, attaining 100 per cent of the strength of the unwounded tissue in 14 to 21 days. Braided synthetic absorbable sutures appear to be suited ideally for closure of incised wounds of a urinary conduit. They maintain their tensile strength for approximately 21 days, during which time the healing tissues regain strength rapidly. Because sutures are foreign bodies and have access to urine, they may serve as a nidus for stone formation. Several factors that have been identified as important determinants of foreign body urolithiasis include the presence of urine, urine volume and pH, infection, physical and chemical configuration of the foreign body, and animal species. The incidence of suture urolithiasis is related directly to the duration in which the sutures are present in the urinary tract. Consequently, absorbable sutures are preferred over nonabsorbable sutures for closure of wounds of the urinary conduit. In the absence of infection braided synthetic absorbable sutures have distinct advantages over gut sutures for closure of urinary tract wounds. They are absorbed by nonenzymatic hydrolysis in a predictable manner with limited inflammatory response. In contrast, gut sutures have an unpredictable absorption rate by enzymatic degradation and elicit an exaggerated inflammatory response. Because infected urine, especially Proteus species, accelerates the degradation of absorbable synthetic sutures to a greater degree than gut sutures, wound closure in the presence of infection should be accomplished with the absorbable natural fiber suture. Nonabsorbable sutures or staples should not be used in the urinary tract because they predictably promote urolithiasis. 相似文献
10.